News
Biologics, Women, and Pregnancy: What’s Known?
As more studies emerge each year, recommendations will become stronger for considering treatment by certain biological drugs, taking into account...
News
CDC says about 20% get long COVID. New models try to define it
“Those numbers are high and it’s alarming. But we’ve been sounding the alarm for quite some time, and we’ve been assuming that about one in five...
News
Childhood survivors of gun violence: What’s the long-term outlook?
While parents may be inclined to baby the kids after the violence, it’s important to maintain routines.
News
Pick your sunscreen carefully: 75% don’t pass muster
Overall, about 1 in 4 sunscreens, or about 500 products, met standards for providing adequate sun protection and avoiding ingredients linked to...
News
FDA warns companies selling OTC skin lighteners
Among the side effects associated with hydroquinone products reported to the FDA are skin rashes, facial swelling, and skin discoloration or...
News
Strawberries, spinach, kale: high on the ‘Dirty Dozen’ list
“Our recommendation is to buy the ones on the ‘Dirty Dozen’ list organic when available, or focus on the ‘Clean 15’ list.”
News
Oral tofacitinib produces hair regrowth in children with alopecia areata
“It is important to get information into the literature about potential treatments for severe alopecia areata because there is no FDA-approved...
News
Third transplant patient cured of HIV marks important firsts
“A bone marrow transplant is not a viable large-scale strategy for curing HIV, but it does present a proof of concept that HIV can be cured.”
News
No COVID vax, no transplant: Unfair or good medicine?
Is removing them from the list unfair and cruel, or simply business as usual?
News
More than a month after launch, iPLEDGE glitches persist
The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group, the manufacturers responsible for the FDA-...
News
New CDC COVID-19 isolation guidelines still up for debate among experts
Sparking the most debate: Infected people are not told to test before leaving isolation.
News
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issues
American Academy of Dermatology Association representatives described the severe impact on patient access to treatment.
News
iPLEDGE rollout described as a failure, chaotic, and a disaster
The switch to a new platform was met with frustration from physicians, pharmacists, and patients alike.
News
Fixing the maternal health problem in the U.S.: Signs of hope?
Hundreds of women die in pregnancy or in weeks after birth each year.